Magnetische Medikamente
Wirkstoffe können zielgenau zu befallenen Zellen geschickt werden.
PI: Sebastian Schwaminger
Focus: Nanomaterials for Drug Delivery
A central topic is the use of magnetic nanomaterials for medical and pharmaceutical applications. In particular, iron oxide-based nanomaterials are to be used to enable magnetically controlled drug delivery. In addition to the material properties and the functionalization of the materials, the magnetic transport processes are also examined. The transport in complex fluids, such as those found in blood and other body vessels, is being researched. The aim is to develop stimuli-responsive materials for pharmaceutical agents for cancer treatment. In addition to material science studies and spectroscopic characterizations such as infrared spectroscopy (FTIR), the focus of characterization is also on the biocompatibility of the materials. The interaction of the materials with cells is to be examined, with a special focus on oxidative stress. One focus is on instrumental analysis (HPLC) for the characterization of surface affinity and for the determination of oxidative stress markers.
Network: In addition to the collaboration within the Otto-Loewi Research Center, a strong network within the Medical University of Graz is aspired. Cooperations on national level do exist with Eva Roblegg (KFU Graz), ), Anita Emmerstorfer-Augustin (TU Graz), Sandro Keller (KFU Graz) and Daniel Baumgarten (UMIT). On an international level collaborations with Sonja Berensmeier (TU München), Thomas Becker (TU München), Karsten Haupt (TU Compiègne), Borislav Tzankov (MU Sofia), Peter Braun (Fraunhofer ITMP-IIP, Penzberg), Dominik Szwajgier (ULS Lublin), Somdet Srichairatanakool (Chiang Mai University), Aida Smajlovic (Universität Tuzla), Sara Reda Al-Aswad (Damanhour University), Kalayou Hiluf Gebremdhin (Mekelle University), Olusola Ladokun (Lead City University), and Peraphan Pothacharoen (Chiang Mai University).
The BioPor-PDT project is a collaboration between the Medical University of Graz (Austria) and Mekelle University (Ethiopia). It aims to develop an innovative porphyrin-loaded hydrogel therapy for the treatment of multidrug-resistant Candida albicans, particularly in HIV-positive patients suffering from oral candidiasis.
Project duration: 2026–2027
Funded by: Africa-UniNet und BMFWF
Project partners: Kalayou Hiluf Gebremdhin (Mekelle University)
FERMENT-HEALTH is a bilateral research project between the Medical University of Graz (Austria) and Lead City University Ibadan (Nigeria). The project investigates the health benefits of traditional Nigerian fermented foods—such as Ogi, Iru, Fufu, and Garri—focusing on their effects on gut microbiota composition and their potential to prevent metabolic diseases such as obesity and type 2 diabetes.
Project duration: 2026–2027
Funded by: Africa-UniNet und BMFWF
Project partners: Olusola Ladokun (Lead City University)
The PRONANO project brings together the Medical University of Graz (Austria) and Damanhour University (Egypt) to explore the isolation, characterization, and application of probiotic yeasts from traditional dairy products. The project develops advanced nanotechnology-based encapsulation systems to improve the stability, functionality, and targeted delivery of probiotics for use in functional foods and potential therapeutic products.
Project duration: 2026–2027
Funded by: Africa-UniNet und BMFWF
Project partners: Sara R. Al-Aswad (Damanhour University)
This project aims to develop an innovative platform for the treatment of HER2-positive breast cancer. Using genetically modified M13 bacteriophages that display HER2-specific ligands and carry the apoptosis-inducing TRAIL molecule, the goal is to enable precise, low-toxicity cancer treatment. Functionalized magnetic nanoparticles are also used to improve stability, enable controlled release, and support future imaging applications.
Project duration: 2026–2027
Funded by: ASEA-UniNet und BMFWF
Project partners: Peraphan Pothacharoen (Chiang Mai University)